Human Reproduction, Vol 13, 360-362, Copyright © 1998 by Oxford University Press
R Haimov-Kochman and E Ben-Chetrit
Colchicine is used for the treatment of various diseases including gouty
arthritis, familial Mediterranean fever (FMF) and Behcet's disease. As a
modulator of the microtubules at the cytoskeleton level, it arrests cell
division at metaphase and inhibits microtubular- dependent cell motility.
Controversy exists as to the adverse effect of colchicine on sperm
production and function in healthy subjects as well as in gout, FMF and
Behcet's patients. Sperm analysis shows a spectrum of pathology, from
oligo- and azoospermia to normospermia with disturbances in sperm motility.
These inconsistent sperm pathologies can be explained in part by the
variability of the pathophysiology of the underlying disease. Thus, it
seems that colchicine by itself may not have a significant direct adverse
effect on sperm production and function.
REVIEWS
The effect of colchicine treatment on sperm production and function: a review
Department of Obstetrics and Gynecology, Hadassah University Hospital, Mount Scopus, Jerusalem, Israel.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Kallinich, D. Haffner, T. Niehues, K. Huss, E. Lainka, U. Neudorf, C. Schaefer, S. Stojanov, C. Timmann, R. Keitzer, et al. Colchicine Use in Children and Adolescents With Familial Mediterranean Fever: Literature Review and Consensus Statement Pediatrics, February 1, 2007; 119(2): e474 - e483. [Abstract] [Full Text] [PDF] |
||||
